Clinical Trial Update: Cannabinoids for Behavioral Problems in Children With ASD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating cannabinoids for behavioral problems in children with autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Autistic Disorder | Phase 2 | Status: COMPLETED